Logo image of BRG

BLUEROCK RESIDENTIAL GROWTH (BRG) Stock Fundamental Analysis

NYSEARCA:BRG - NYSE Arca - US09627J1025 - REIT - Currency: USD

26.6  -0.32 (-1.19%)

After market: 26.69 +0.09 (+0.34%)

Fundamental Rating

1

Taking everything into account, BRG scores 1 out of 10 in our fundamental rating. BRG was compared to 128 industry peers in the Diversified REITs industry. Both the profitability and financial health of BRG have multiple concerns. BRG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BRG was profitable.
BRG Yearly Net Income VS EBIT VS OCF VS FCFBRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 1.72%
ROE 4.16%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRG Yearly ROA, ROE, ROICBRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 2 -2 4 6 8

1.3 Margins

Industry RankSector Rank
OM 14.78%
PM (TTM) 19.49%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRG Yearly Profit, Operating, Gross MarginsBRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

BRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRG has been increased compared to 1 year ago.
The debt/assets ratio for BRG has been reduced compared to a year ago.
BRG Yearly Shares OutstandingBRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
BRG Yearly Total Debt VS Total AssetsBRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

A Debt/Equity ratio of 1.32 is on the high side and indicates that BRG has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.16%
BRG Yearly LT Debt VS Equity VS FCFBRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

BRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.13%, which is quite impressive.
Measured over the past years, BRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 46.75% on average per year.
BRG shows a small growth in Revenue. In the last year, the Revenue has grown by 6.19%.
BRG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.18% yearly.
EPS 1Y (TTM)128.13%
EPS 3Y46.75%
EPS 5YN/A
EPS Q2Q%-60.03%
Revenue 1Y (TTM)6.19%
Revenue growth 3Y6.1%
Revenue growth 5Y22.18%
Sales Q2Q%10.69%

3.2 Future

BRG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -43.17% yearly.
Based on estimates for the next years, BRG will show a small growth in Revenue. The Revenue will grow by 1.74% on average per year.
EPS Next Y-1275.53%
EPS Next 2Y-190.74%
EPS Next 3Y-79.15%
EPS Next 5Y-43.17%
Revenue Next Year11.08%
Revenue Next 2Y1.8%
Revenue Next 3Y1.59%
Revenue Next 5Y1.74%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRG Yearly Revenue VS EstimatesBRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BRG Yearly EPS VS EstimatesBRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 147.78 indicates a quite expensive valuation of BRG.
When comparing the Price/Earnings ratio of BRG to the average of the S&P500 Index (29.62), we can say BRG is valued expensively.
The Forward Price/Earnings Ratio is negative for BRG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 147.78
Fwd PE N/A
BRG Price Earnings VS Forward Price EarningsBRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.58
BRG Per share dataBRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

BRG's earnings are expected to decrease with -79.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-190.74%
EPS Next 3Y-79.15%

More info and screens

2

5. Dividend

5.1 Amount

BRG has a Yearly Dividend Yield of 2.43%.
Compared to an average S&P500 Dividend Yield of 2.27, BRG has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.43%

5.2 History

BRG has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
BRG Yearly Dividends per shareBRG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8 1

5.3 Sustainability

194.52% of the earnings are spent on dividend by BRG. This is not a sustainable payout ratio.
DP194.52%
EPS Next 2Y-190.74%
EPS Next 3Y-79.15%
BRG Yearly Income VS Free CF VS DividendBRG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M
BRG Dividend Payout.BRG Dividend Payout, showing the Payout Ratio.BRG Dividend Payout.PayoutRetained Earnings

More info and screens

BLUEROCK RESIDENTIAL GROWTH

NYSEARCA:BRG (10/5/2022, 8:22:26 PM)

After market: 26.69 +0.09 (+0.34%)

26.6

-0.32 (-1.19%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-30 2022-08-30/bmo
Earnings (Next)11-03 2022-11-03/bmo
Inst Owners1.72%
Inst Owner Change0%
Ins Owners2.69%
Ins Owner Change0%
Market Cap813.29M
Analysts45
Price Target28.56 (7.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.43%
Yearly Dividend0.65
Dividend Growth(5Y)N/A
DP194.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 147.78
Fwd PE N/A
P/S 3.48
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB N/A
EV/EBITDA 16.58
EPS(TTM)0.18
EY0.68%
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.65
BVpS35.81
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.72%
ROE 4.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.78%
PM (TTM) 19.49%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.13%
EPS 3Y46.75%
EPS 5YN/A
EPS Q2Q%-60.03%
EPS Next Y-1275.53%
EPS Next 2Y-190.74%
EPS Next 3Y-79.15%
EPS Next 5Y-43.17%
Revenue 1Y (TTM)6.19%
Revenue growth 3Y6.1%
Revenue growth 5Y22.18%
Sales Q2Q%10.69%
Revenue Next Year11.08%
Revenue Next 2Y1.8%
Revenue Next 3Y1.59%
Revenue Next 5Y1.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A